High resolution neural implants for the treatment of epilepsy
An Australian MedTech company developing miniaturised, high resolution seizure prediction technology to improve epilepsy outcomes.
Carbon Cybernetics is an Australian MedTech company developing miniaturised, high resolution seizure prediction technology to improve the lives of those suffering from neurological diseases.
Delivered by MTPConnect, the Australian Government’s $45 million BioMedTech Horizons program, is a Medical Research Future Fund (MRFF) initiative to support innovative collaborative health technologies, drive discoveries towards proof-of-concept and commercialisation that address key health challenges as well as maximise entrepreneurship and idea potential.
Technology Features
Our world-leading team has developed carbon-based implants for carbon-based lifeforms. These devices are suitable for life-long implantation and use brain signals to forecast seizure activity.
Carbon-based Materials
Our materials are biocompatible, low-density, and corrosion-resistant, making them the ideal choice for long-term medical implants.
High Resolution
We produce one of the highest density recording electrode arrays on the market. The diameters of our electrodes are smaller than those of neurons.
Flexible Electrodes
Our ultra small carbon fibre electrodes cause minimal tissue damage upon implantation and reduce the chance of ongoing tissue damage.
Minimal Surgical Risk
Our neural implants can be inserted or "injected" through a small hole, negating the need for a full craniotomy typically required for other implants.
featured on
Curious to know more?
Get in touch with us today and ask about our new seizure forecasting technology.
